Turoctocog alfa
Results: 2
| # | Item |
|---|---|
1 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. ----------------------------DOSAGE FORAdd to Reading ListSource URL: labeling.cslbehring.comLanguage: English - Date: 2016-05-26 14:29:43 |
2![CLINICAL PHARMACOLOGY BLA REVIEW Division of Hematology Office of Blood Review & Research STN[removed]Sponsor: Novo Nordisk Product: Antihemophilic Factor (recombinant), plasma/albumin free (NovoEight) Turoctocog alfa](https://www.pdfsearch.io/img/3ba94b26ff4ae89ea93263932a701cf9.jpg "CLINICAL PHARMACOLOGY BLA REVIEW Division of Hematology Office of Blood Review & Research STN[removed]Sponsor: Novo Nordisk Product: Antihemophilic Factor (recombinant), plasma/albumin free (NovoEight) Turoctocog alfa") | CLINICAL PHARMACOLOGY BLA REVIEW Division of Hematology Office of Blood Review & Research STN[removed]Sponsor: Novo Nordisk Product: Antihemophilic Factor (recombinant), plasma/albumin free (NovoEight) Turoctocog alfaAdd to Reading ListSource URL: www.fda.govLanguage: English |